Jenburkt Pharmaceuticals has submitted to a copy of the notice published on November 24, 2016 in the newspapers in accordance with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, audit, transfer and Refund) Rules, 2016, in respect of transfer of Equity shares of the Company to the Investor Education and Protection Fund (IEPF) Suspense Account.
The above information is a part of company’s filings submitted to BSE.